Isaac Veinbergs

Aptuit LLC engages in the development of pharmaceutical and biotechnological products. Its offerings include drug design and discovery, preclinical biosciences, API development and manufacture, solid state chemistry, solid and oral dosage form development and manufacture, integrated drug discovery and drug development, Aptuit INDiGO, and physical and analytical chemistry services. The company was founded in December 2004 and is headquartered in Greenwich, CT.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

Dolby Family Ventures (Dolby) is a venture capital firm founded in 2013. The firm is headquartered in San Francisco, California.

Caldan Therapeutics Ltd. provides novel therapeutics targeting free fatty acid. It focuses on developing drugs in order to deliver anti-diabetic effects in multiple tissues and organs. The company was founded by Graeme Milligan and Trond Ulven and is headquartered in Edinburgh, the United Kingdom.

Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022.

Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA.

Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI.

NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH.

Theolytics Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Oxford, the United Kingdom.

QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA.

Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA.

Reservoir Neuroscience, Inc. develops novel therapeutics. It focuses on treating dysfunctional blood vessels in the brain other neurological disorders. The company was founded by Aaron Friedman in 2019 and is headquartered in Berkeley, CA.

OSTHUS Group GmbH operates as a database management company. The firm supports regulated industries in developing data. It specializes in data integration, management, intelligence, and analytics. The company was founded by Torsten Osthus in 1996 and is headquartered in Aachen, Germany.

Xenocor, Inc. is a privately held corporation based in Utah that offers a suite of leading-edge, fog-free, disposable surgical technologies for minimally invasive, abdominal, and thoracic procedures. The American company also offers a suite of leading-edge, fog-free, single-use endoscopes for minimally invasive surgical procedures. These products emerged from the Center for Medical Innovation and are FDA cleared, CE marked, and patent protected. The company was founded by John Langell, Lane Brooks, and Sourav Kole, and the CEO is Evan Kelso.

Epidarex Exeed Ltd. is a British biotechnology company that specializes in research and experimental development. The company is based in Edinburgh, UK. The company was founded in 2019 by Elizabeth Ann Roper and Henning Steinhagen, with Henning Steinhagen serving as the CEO since its inception.

Paros Bio, Inc. is a private company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. The company is focused on developing a gene replacement approach to treat autosomal dominant Alzheimer's disease (ADAD). Specifically, they are working on a gene therapy that targets mutations in the presenilin 1 gene (PSEN1), which is the underlying genetic cause of ADAD.